HALO logo

Halozyme Therapeutics (HALO) Short term debt

Annual short term debt:

N/A
December 31, 2024

Summary

  • HALO annual short term debt is not available.

Performance

HALO Short term debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Range

Earnings dates

OtherHALObalance sheet metrics

quarterly short term debt:

N/A
March 31, 2025

Summary

  • HALO quarterly short term debt is not available.

Performance

HALO quarterly short term debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Range

Earnings dates

OtherHALObalance sheet metrics

Short term debt Formula

Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings

HALO Short term debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year--
3 y3 years--
5 y5 years--

HALO Short term debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year
5 y5-year
alltimeall time

HALO Short term debt History

DateAnnualQuarterly
Dec 2022
$13.33M(-85.1%)
$13.33M(+0.1%)
Sep 2022
-
$13.31M(-86.6%)
Jun 2022
-
$99.05M(+10.6%)
Mar 2022
-
$89.55M(+0.1%)
Dec 2021
$89.42M(-77.5%)
$89.42M(+0.2%)
Sep 2021
-
$89.25M(+0.1%)
Jun 2021
-
$89.17M(+0.1%)
Mar 2021
-
$89.04M(-77.6%)
Dec 2020
$397.23M(+1932.7%)
$397.23M(>+9900.0%)
Mar 2020
-
$2.86M(-85.4%)
Dec 2019
$19.54M(-78.6%)
$19.54M(-64.2%)
Sep 2019
-
$54.54M(-23.1%)
Jun 2019
-
$70.88M(-18.2%)
Mar 2019
-
$86.66M(-5.3%)
Dec 2018
$91.51M(+18.5%)
$91.51M(+3.4%)
Sep 2018
-
$88.52M(+1.8%)
Jun 2018
-
$86.97M(+5.5%)
Mar 2018
-
$82.46M(+6.8%)
DateAnnualQuarterly
Dec 2017
$77.21M(+343.9%)
$77.21M(+25.7%)
Sep 2017
-
$61.43M(+35.0%)
Jun 2017
-
$45.52M(+53.8%)
Mar 2017
-
$29.60M(+70.2%)
Dec 2016
$17.39M(-20.4%)
$17.39M(+40.3%)
Sep 2016
-
$12.39M(+276.9%)
Jun 2016
-
$3.29M(-88.0%)
Mar 2016
-
$27.42M(+25.4%)
Dec 2015
$21.86M
$21.86M(+39.3%)
Sep 2015
-
$15.70M(+62.6%)
Jun 2015
-
$9.66M(+158.9%)
Mar 2015
-
$3.73M(-63.0%)
Sep 2014
-
$10.07M(+62.4%)
Jun 2014
-
$6.20M(+158.0%)
Mar 2014
-
$2.40M(-59.7%)
Sep 2013
-
$5.97M(+63.9%)
Jun 2013
-
$3.64M(+167.5%)
Mar 2013
-
$1.36M

FAQ

  • What is the all time high annual short term debt for Halozyme Therapeutics?
  • What is the all time high quarterly short term debt for Halozyme Therapeutics?

What is the all time high annual short term debt for Halozyme Therapeutics?

Halozyme Therapeutics all-time high annual short term debt is $397.23M

What is the all time high quarterly short term debt for Halozyme Therapeutics?

Halozyme Therapeutics all-time high quarterly short term debt is $397.23M
On this page